ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 790,12
1,44%
DAX
18 518,03
-0,44%
Brent Oil
83,29
-1,24%
Bitcoin
64 572,18
-0,44%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Insmed Inc (INSM)

  7. Insmed Inc (INSM) Actualités

INSM

Insmed (INSM)

Insmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateHeureSourceTitreSymboleSociété
02/11/202313h00PR Newswire (US)Insmed Holds Second Annual Global Day of Good to Benefit Communities Across the GlobeNASDAQ:INSMInsmed Inc
31/10/202321h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
27/10/202321h57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INSMInsmed Inc
26/10/202322h05PR Newswire (US)Insmed Ranks No. 1 on Science's 2023 Top Biopharma Employers ListNASDAQ:INSMInsmed Inc
26/10/202313h38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INSMInsmed Inc
26/10/202313h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INSMInsmed Inc
26/10/202313h30PR Newswire (US)Insmed Reports Third-Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
24/10/202314h00PR Newswire (US)Insmed and Google Cloud Collaborate to Transform the Lives of Patients by Harnessing the Power of AINASDAQ:INSMInsmed Inc
12/10/202314h00PR Newswire (US)Insmed to Host Third-Quarter 2023 Financial Results Conference Call on Thursday, October 26, 2023NASDAQ:INSMInsmed Inc
06/10/202314h00PR Newswire (US)Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:INSMInsmed Inc
26/09/202314h00PR Newswire (US)Insmed To Present at Chardan's 7th Annual Genetic Medicines ConferenceNASDAQ:INSMInsmed Inc
06/09/202314h00PR Newswire (US)Insmed To Present at the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:INSMInsmed Inc
05/09/202313h00PR Newswire (US)INSMED ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 3 ARISE STUDY OF ARIKAYCE® (AMIKACIN LIPOSOME INHALATION SUSPENSION) IN PATIENTS WITH NTM LUNG DISEASE CAUSED BY MACNASDAQ:INSMInsmed Inc
03/08/202313h30PR Newswire (US)Insmed Reports Second-Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
20/07/202314h00PR Newswire (US)Insmed to Host Second-Quarter 2023 Financial Results Conference Call on Thursday, August 3, 2023NASDAQ:INSMInsmed Inc
07/07/202322h05Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:INSMInsmed Inc
15/06/202322h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INSMInsmed Inc
07/06/202314h00PR Newswire (US)Insmed To Present at the Goldman Sachs 44th Annual Global Healthcare ConferenceNASDAQ:INSMInsmed Inc
22/05/202322h05PR Newswire (US)Insmed Presents Range of New Study Findings at American Thoracic Society 2023 International ConferenceNASDAQ:INSMInsmed Inc
19/05/202322h23Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:INSMInsmed Inc
15/05/202319h52Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:INSMInsmed Inc
11/05/202322h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INSMInsmed Inc
08/05/202313h30PR Newswire (US)Insmed Unveils New Research Platforms and Capabilities at Investor and Analyst Event, "The Future of Rare at Insmed: Functional Genes, AI-Enhanced Proteins, Glowing Algae, and More"NASDAQ:INSMInsmed Inc
04/05/202313h32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INSMInsmed Inc
04/05/202313h30PR Newswire (US)Insmed Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
24/04/202314h00PR Newswire (US)Insmed to Host Investor and Analyst Event on May 8, 2023NASDAQ:INSMInsmed Inc
20/04/202314h00PR Newswire (US)Insmed to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 4, 2023NASDAQ:INSMInsmed Inc
31/03/202322h11Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INSMInsmed Inc
31/03/202322h10Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:INSMInsmed Inc
31/03/202314h00PR Newswire (US)Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in BronchiectasisNASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM

Dernières Valeurs Consultées

EU
EN
Bouygues
NYSE
NKE
Nike
EU
PX1
CAC 40
EU
HO
Thales
EU
SGO
Cie de SaintGobain
FTSE
UKX
FTSE 100
EU
CAP
Capgemini
EU
PX4
SBF 120
NYSE
MRK
Merck
EU
VK
Vallourec
EU
ACA
Credit Agricole
NASDAQ
NVDA
NVIDIA
NYSE
DIS
Walt Disney
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés